References
- Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017
- World Health Organization. Statement on the second meeting of the International Health Regulations. (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, Switzerland: World Health Organization. [Cited 2020 Mar 15]. Available at: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
- World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - Mar 11 2020. [cited 2020 Mar 15]. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
- World Health Organization. Coronavirus disease (COVID-19) outbreak situation. [cited 2020 March 25]. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
- World Health Organization. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. [cited 2020 Jan 24]. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance.
- National Health Commission of the People's Republic of China. National COVID-19 diagnosis and treatment scheme (the seventh edition). [cited 2020 Mar 3]. Available at: http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032
- Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi: 10.1016/S0140-6736(20)30154-9
- Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406–1407. doi: 10.1001/jama.2020.2565
- Tong ZD, Tang A, Li KF, et al. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province, China, 2020. Emerg Infect Dis. 2020;26(5):1052–1054. doi: 10.3201/eid2605.200198
- Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295(3):200463. doi: 10.1148/radiol.2020200463
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3
- Tian S, Hu N, Lou J, et al. Characteristics of COVID-19 infection in Beijing. J Infect. 2020;80(4):401–406. doi: 10.1016/j.jinf.2020.02.018
- Wu J, Liu J, Zhao X, et al. Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study [published online ahead of print, 2020 Feb 29]. Clin Infect Dis. 2020; ciaa199.
- World Health Organization. Clinical management of COVID-19: interim guidance. May 27, 2020. [cited 2020 June 15]. Available at: https://www.who.int/publications/i/item/clinical-management-of-covid-19.pdf.
- Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. June 16, 2020. [cited 2020 June17]. Available at: https://www.nature.com/articles/d41586-020-01824-5.
- Guo L, Wei D, Zhang X, et al. Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA Score. Front Microbiol. 2019;10:2752. doi: 10.3389/fmicb.2019.02752
- Leung C. Clinical features of deaths in the novel coronavirus epidemic in China. Rev Med Virol. 2020;30(3):e2103. doi: 10.1002/rmv.2103
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. doi: 10.1001/jama.2020.2648
- Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-51.
- National Health Comission of the People's Republic of China. Novel coronavirus pneumonia epidemic situation. [cited 2020 Feb 2020]. Available at: http://www.nhc.gov.cn/yjb/s7860/202003/9d462194284840ad96ce75eb8e4c8039.shtml.
- World Health Organization. Coronavirus disease 2019 (COVID-19) situation report 40. [cited 2020 29 Feb 29]. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf.
- Liu W, Tao ZW, Lei W, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020; 133(9):1032–1038. doi: 10.1097/CM9.0000000000000775